The role of macrophages in tumour revascularisation following vascular disrupting treatment
The vascular disrupting agent, combretastatin-A-4-phosphate (CA-4-P), induces rapid and selective shutdown of the tumour vasculature and secondary tumour cell death. However, blood flow effects are often reversed within 24 hours of a single dose, accompanied by re-vascularisation and continuation of...
| Main Author: | |
|---|---|
| Published: |
University of Sheffield
2010
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.557627 |